Global Veterinary Parasiticides Market- Market Dynamics
Veterinary pharmaceuticals, including parasiticides, have transformed the health of companion and livestock animals across the globe over the past two decades. Today, the spectrum of parasiticides for veterinary applications continues to expand with a variety of ectoparasiticides, endoparasiticides, and endectocides that are launched every year. Constant innovations are leading to the emergence of novel parasiticide delivery systems as well in this market.
Some of the key factors driving the market towards growth are:
Increase in pet ownership
Intensifying consumer focus on food safety
Greater livestock production rates
Increasing food-borne diseases
Some of the factors restraining the market are:
Scarcity of arable land and water
Increased competition for cultivated land
Increased competition for cost-effective production
The global veterinary parasiticides market can be segmented on the basis of disease-causing organisms into Ectoparasiticides (fleas, lice, mites) and Endoparasiticides (gastrointestinal nematode, heartworms, lungworms). By products, the market can be segmented into oral liquids, tablets, injectables, sprays, pour on, spot on, collars, and ear tags. By species, the market can be further classified into companion animals (dogs, cats, horses, and others) and farm animals (cattle, swine, poultry, fish, and sheep). Lastly, by geography, the market can be divided into North America (US, Canada, Mexico), Europe (France, Italy, Germany, Spain, Sweden, Rest of Europe), and Asia-Pacific (China, Japan, India, Rest of Asia-Pacific).
Major Companies in the Sector Include:
- Bayer Healthcare
- Boehringer Ingelheim
- Ceva Animal Health, Inc.
- Merial (Animal Health Division of Sanofi)
Market analysis for the veterinary parasiticides market, with region specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the veterinary parasiticides market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Market Definition
1.2 Market Recent Trends
2. Market Analysis
2.1 Market Animal Health Products
2.2 Animal medicines vs. human Medicines
3. Market Dynamics
3.1 Market Drivers
3.1.1 Increase in pet ownership
3.1.2 Improved Nutrition
3.1.3 Intensifying consumer focus on food safety
3.1.4 Greater Livestock production
3.1.5 Increasing Zoonotic and Foodborne Diseases
3.2 Market Constraints
3.2.1 Scarcity of arable land and water
3.2.2 Increased competition for cultivated land
3.3.3 Cost-effective production
3.3 Porter's Five Force Analysis
3.3.1 Threat of New Entrant
3.3.2 Internal Rivalry
3.3.3 Buyer bargaining power
3.3.4 Supplier bargaining power
3.3.5 Threat of substitutes
4.Global veterinary parasiticides market Segmentation
4.1 Global veterinary Parasiticides Market, By disease causing organisms
188.8.131.52 Gastrointestinal nematode
4.2 Global veterinary Parasiticides Market, By products
4.2.1 Oral Liquids
4.2.5 Pour On
4.2.6 Spot On
4.2.8 Ear Tags
4.3 Global veterinary Parasiticides Market, By species
4.3.1 Companion Animals
4.3.2 Farm animal
4.4 .Global Veterinary Market Segmentation, By Geography
4.4.1 North America
184.108.40.206 Rest of Europe
220.127.116.11 Rest of Asia-Pacific
5. Competitive landscape
5.1 Major players in the market
5.2 Mergers and acquisitions
5.3 New product launches
5.4 Agreement, Collaborations, and Partnerships
5.5 Recommendations for New players in the market
5.6 Recommendations for Existing players in the market
6. Company profiles
6.1 Zoetis animal healthcare
6.1.1 Financial Overview
6.1.2 Business overview
6.1.3 Business strategies
6.2.1 Financial Overview
6.2.2 Business overview
6.2.3 Business strategies
6.3 Merial (Animal Health Division Of Sanofi)
6.3.1 Financial Overview
6.3.2 Business overview
6.3.3 Business strategies
6.4.1 Financial Overview
6.4.2 Business overview
6.4.3 Business strategies
6.5 Bayer healthcare
6.5.1 Financial Overview
6.5.2 Business overview
6.5.3 Business strategies
6.6 Ceva Animal Health, Inc.
6.6.1 Financial Overview
6.6.2 Business overview
6.6.3 Business strategies
6.7.1 Financial Overview
6.7.2 Business overview
6.7.3 Business strategies
6.8 Boehringer Ingelheim
6.8.1 Financial Overview
6.8.2 Business overview
6.8.3 Business strategies